|
Strong growth momentum validated by record financial results:
- Turnaround in FY2014: Highest revenue registered for the past 6 years since 2009; Highest EPS and net profit margin reported in the past 5 years since 2010
- Continue strong growth momentum in 1H2015: Best World 1H2015 earnings grew to $2.5 million
- 2Q2015 revenue from key markets Taiwan and China grew by year-on-year to $10.2 million and $5.4 million respectively.
For FY2014, sales from Taiwan and China increased by 71.9% and 404.9% respectively.
Growth Catalyst:
- On track for China direct selling license application which will open up the doors to the multi-billion direct selling dollar industry that currently has only 40+ licenses issued in China
- The Group's business in China continued to exhibit consistent growth in 1H2015, with revenue up by 54.0% to hit $8.4 million, due to higher export orders from China agent.
The Manufacturing/Wholesale segment's (network of >10,000 drug stores in 31 PRC provinces) strong performance will further increase brand awareness and stimulate demand in the market, while waiting for the approval of Best World's direct-selling licence application.
- The group is currently leveraging on its Chinese retail partners to establish presence in the market, but with a lower margin as a trade-off.
Once the group obtains access into the direct selling industry in China, management is expecting to see profit contribution from China to increase as it captures the full margin via the direct selling channel.
Recent story: BEST WORLD: Takeaways from discussion on direct-selling prospects in China